Production

Eisai Pharmatechnology & Manufacturing Private Limited operates as a manufacturer of pharmaceutical ingredients and formulations. The company was founded in 2007 and is based in Visakhapatnam, India. Eisai Pharmatechnology & Manufacturing Private Limited operates as a subsidiary of Eisai Co. Ltd.

Marion Biotech strongly believes in an integrated approach to healthcare. It is also engaged in extensive Research & Development of unique Herbal products. At Marion Biotech, we set Stringent Standards of Quality, Safety and Efficacy for all the Products that we manufacture.

Troikaa mainly focuses on Novel Drug Delivery Systems (NDDS). The company firmly believes in providing superior therapeutic benefits by improvising the formulations through Innovative Technologies.
Six patents have been filed in various areas of drug delivery. To handle competition, Troikaa adopted various multifaceted strategies to help stand their ground in the competitive market. Another fact that helps us stand out is their high quality products.

Natural Remedies, a pioneer in phytopharmaceuticals is today credited with integrating scientific approach to search medicines and health supplements ensuring purity, safety and affordability. Our diversified solutions blend the understanding of benefits of medicinal herbs with modern science to develop and provide Herbal Veterinary Medicines, Human Health Supplements, Animal Health Products and Standardized Herbal Extracts.

Recruitment of Professional Consultant, Technical Data Associates, Data Entry Operators and Office Assistants in the Office of CDSCO on contractual basis- applications regarding -

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.